INSIGHTS AND RECOMMENDATIONS

1. OVERALL RESULTS

Finding
The dataset contains 101,766 hospital encounters, including 11,357 encounters followed by readmission within 30 days. The overall 30-day readmission rate is 11.16%.

Recommendation
Use the overall rate as a descriptive baseline when comparing groups. Always display encounter counts alongside rates. Encounters are not unique patients.

Calculation notes
Readmission rate = 30-day readmission count / encounter count x 100.
Difference from overall rate = group rate minus overall rate, expressed in percentage points (pp). Rates and differences below were recalculated from the supplied counts using the unrounded overall rate before rounding to two decimal places.

2. PREVIOUS INPATIENT UTILIZATION

Finding
Encounters involving three or more previous inpatient visits had the highest observed 30-day readmission rate among the supplied inpatient groups, at 25.66%. Most encounters were in the group with no previous inpatient visits.

Evidence
Group | Encounters | 30-day readmissions | Rate | Difference from overall
0     | 67,630     | 5,706               | 8.44%  | -2.72 pp
1     | 19,521     | 2,523               | 12.92% | +1.76 pp
2     | 7,566      | 1,319               | 17.43% | +6.27 pp
3+    | 7,049      | 1,809               | 25.66% | +14.50 pp

Business interpretation
Readmission rates increased across the supplied previous-inpatient groups. The 3+ group had a substantially higher observed rate than the group with no previous inpatient visits.

Recommendation
Consider repeated inpatient utilization as a candidate indicator for further review when evaluating targeted follow-up processes. Any operational intervention requires clinical review and evaluation.

Limitation
This association does not show that previous admissions cause readmission. The groups may differ in other characteristics.

3. MEDICATION DISTRIBUTION

Finding
Most encounters involved 11-20 medications.

Evidence
Medication group | Encounters | Share of all encounters
1-10             | 25,861     | 25.41%
11-20            | 52,025     | 51.12%
21-30            | 18,643     | 18.32%
31+              | 5,237      | 5.15%

Recommendation
Use these groups for readable dashboard comparisons and retain the original numeric count for modeling.

Limitation
These counts describe medication distribution. Readmission rates by medication group were not supplied, so no medication-readmission relationship is concluded here.

4. PATIENT AND CLINICAL FINDINGS

4.1 AGE

Finding
The supplied 21-30 age group had the highest observed readmission rate among the four reported age groups.

Evidence
Reported age group | Encounters | 30-day readmissions | Rate
0-10               | 161        | 3                   | 1.86%
10-20              | 691        | 40                  | 5.79%
21-30              | 1,657      | 236                 | 14.24%
30+                | 99,257     | 11,078              | 11.16%

Business interpretation
The broad 30+ category contains most encounters and may conceal differences among adult age groups.

Recommendation
Validate the age-group definitions and compare the original age bands before drawing age-specific conclusions.

Limitations
The supplied labels 21-30 and 30+ require checking for boundary consistency. Labels are reproduced as provided, not assumed to be verified. The youngest group contains only three readmissions.

4.2 DIAGNOSIS CATEGORY

Finding
Among named diagnosis groups, Diabetes had the highest observed readmission rate at 12.98%, followed by Injury at 12.25%. Circulatory diagnoses accounted for the largest encounter and readmission counts. Missing/Unknown had a higher rate but only 21 encounters.

Evidence
Category          | Encounters | 30-day readmissions | Rate
Circulatory       | 30,336     | 3,474               | 11.45%
Diabetes          | 8,772      | 1,139               | 12.98%
Digestive         | 9,208      | 966                 | 10.49%
Genitourinary     | 5,078      | 549                 | 10.81%
Injury            | 6,974      | 854                 | 12.25%
Missing/Unknown   | 21         | 5                   | 23.81%
Musculoskeletal   | 4,957      | 471                 | 9.50%
Neoplasms         | 3,433      | 346                 | 10.08%
Other             | 22,580     | 2,441               | 10.81%
Respiratory       | 10,407     | 1,112               | 10.69%

Business interpretation
A high readmission rate and a high readmission count describe different priorities. Diabetes had a higher rate, while Circulatory accounted for more readmissions in absolute terms.

Recommendation
Show both rates and counts when comparing diagnosis groups. Investigate missing diagnosis records as a data-quality issue rather than treating their high rate as a reliable ranking.

Limitations
Diagnosis categories depend on the implemented mapping. The Missing/Unknown rate is based on five readmissions and should be interpreted cautiously.

4.3 LENGTH OF STAY

Finding
Observed readmission rates increased across the reported length-of-stay categories.

Evidence
Reported stay group | Encounters | 30-day readmissions | Rate
1                   | 14,208     | 1,162               | 8.18%
2                   | 17,224     | 1,712               | 9.94%
3                   | 17,756     | 1,894               | 10.67%
3+                  | 52,578     | 6,589               | 12.53%

Business interpretation
The group labeled 3+ had a higher observed rate than the one-day group.

Recommendation
Verify the final group's definition. If it excludes exactly three days, rename it 4+ days or More than 3 days. Consider length of stay as a candidate factor for further analysis.

Limitation
A longer stay is associated with higher readmission in this summary, but this does not establish that extending a stay causes readmission.

4.4 A1C RESULT

Finding
Among the three supplied A1C categories, observed readmission rates were close: 9.66%-10.05%.

Evidence
Category       | Encounters | 30-day readmissions | Rate
Greater_than_7 | 3,812      | 383                 | 10.05%
Greater_than_8 | 8,216      | 811                 | 9.87%
Normal         | 4,990      | 482                 | 9.66%
Total shown    | 17,018     | 1,676               |

Business interpretation
These results do not show a steadily increasing readmission rate across the supplied A1C categories. The highest-to-lowest difference is approximately 0.39 percentage points.

Recommendation
Present the observed comparison without claiming a strong relationship. State explicitly that None is excluded and report that category separately if analyzing all encounters.

Limitations
The table covers only 17,018 encounters, not the full dataset. No statistical significance or adjusted association has been established.

4.5 EMERGENCY UTILIZATION

Finding
Observed readmission rates increased across the reported previous emergency-visit groups.

Evidence
Reported group | Encounters | 30-day readmissions | Rate
0              | 90,383     | 9,467               | 10.47%
1              | 7,677      | 1,102               | 14.35%
2              | 2,042      | 373                 | 18.27%
3              | 725        | 147                 | 20.28%
3+             | 939        | 268                 | 28.54%

Business interpretation
Repeated emergency utilization is associated with higher observed readmission rates in these results.

Recommendation
Consider previous emergency utilization as a candidate indicator for further review. Verify whether the final group means four or more visits; if so, rename it 4+ to distinguish it from exactly three visits.

Limitations
The higher-utilization groups are much smaller than the zero-visit group. These are descriptive, unadjusted associations, not causal findings.

5. PREDICTIVE MODEL FINDINGS

5.1 LOGISTIC REGRESSION

Finding
High accuracy concealed very weak detection of actual readmissions.

Evidence
Test encounters: 20,153
Actual 30-day readmissions: 2,151
Accuracy: 89.29%
Precision: 40.91%
Recall: 0.84%
F1-score: 1.64%
Reported ROC-AUC: 0.6338
Reported Average Precision: 0.4091 (requires verification)
Verified Average Precision:

Confusion matrix
Actual outcome | Predicted No | Predicted Yes
No             | 17,976       | 26
Yes            | 2,133        | 18

Business interpretation
The model identified only 18 of 2,151 actual readmissions and missed 2,133. Accuracy alone therefore overstated its usefulness for detecting readmissions.

Recommendation
Evaluate positive-class detection using recall, precision, F1-score and probability-based metrics, alongside a simple baseline.

Verification required
The supplied Average Precision value of 0.4091 is identical to the reported classification precision. This could be a coincidence, but Average Precision cannot be verified from the confusion matrix. Recalculate it using average_precision_score(y_test, logistic_probabilities) before reporting it as confirmed. Likewise, ROC-AUC requires probabilities or scores, not the confusion matrix.

5.2 INITIAL RANDOM FOREST

Finding
The initial Random Forest had higher precision than Logistic Regression but lower recall and F1-score.

Previously reported evidence
Accuracy: 89.34%
Precision: 58.33%
Recall: 0.33%
F1-score: 0.65%

Interpretation
The model made more precise positive predictions but detected very few actual readmissions.

5.3 REVISED RANDOM FOREST

Finding
The revised Random Forest substantially improved recall and F1-score, at the cost of lower precision and accuracy.

Evidence
Accuracy: 64.34%
Precision: 16.34%
Recall: 56.81%
F1-score: 25.38%
Verified final ROC-AUC:
Verified final Average Precision:

Confusion matrix
Actual outcome | Predicted No | Predicted Yes
No             | 11,744       | 6,258
Yes            | 929          | 1,222

Business interpretation
The model identified 1,222 of 2,151 actual readmissions and missed 929. However, it also produced 6,258 false-positive predictions. Only approximately 16 out of every 100 predicted readmissions were correct.

Recommendation
Evaluate whether the improvement in detection justifies the false-alert burden. Compare prediction thresholds using validation data, retain an untouched test set for final evaluation, and consider probability calibration before interpreting scores as reliable individual probabilities.

Limitations
These results do not establish clinical suitability. Higher recall alone does not prove that the model is operationally better; the cost and capacity implications of false alerts also matter.

5.4 MODEL COMPARISON

Model                  | Accuracy | Precision | Recall | F1-score
Logistic Regression    | 89.29%   | 40.91%    | 0.84%  | 1.64%
Initial Random Forest  | 89.34%   | 58.33%    | 0.33%  | 0.65%
Revised Random Forest  | 64.34%   | 16.34%    | 56.81% | 25.38%

The revised Random Forest has the highest reported recall and F1-score among these runs. Final selection should also consider validation results, false-positive burden, and the intended use.

Final selected model:
Selection rationale:
Prediction threshold:
Model configuration:

Probability-metric verification
Random Forest ROC-AUC of 0.655 and Average Precision of 0.1916 were previously reported. Their association with the revised fitted model has not been confirmed, so they are not presented as verified final-model results here. Regenerate predictions, probabilities and all metrics from the same final model before dashboard export.

6. RISK GROUPS AND FEATURE IMPORTANCE

Risk thresholds:
Low-risk encounter count:
Medium-risk encounter count:
High-risk encounter count:
Key risk-group finding:
Most important feature:
Second most important feature:
Third most important feature:

Recommendation
Document the exact thresholds and label risk groups as illustrative, not clinically validated. Export feature importance from the same fitted model used for predictions. Feature importance describes model behavior, not causes of readmission.

7. OVERALL RECOMMENDATIONS AND LIMITATIONS

- Use previous inpatient and emergency utilization as candidates for further investigation, not as proof of causation.
- Show both encounter volume and readmission rate in the dashboard.
- Correct overlapping or ambiguous category labels before publishing.
- Avoid strong conclusions from small groups, especially Missing/Unknown diagnoses.
- Distinguish the full dataset from the test set and filtered subsets.
- Keep metrics, confusion matrices, predictions, risk groups and feature importance consistent with the same final model run.
- No statistical significance tests or adjustment for confounding were supplied for the descriptive comparisons.
- Model results are exploratory portfolio findings and are not validated for clinical decisions.
